Sorrento Therapeutics Inc (OQ:SRNE)

Business Focus: Bio Therapeutic Drugs

Recent Price for SRNE
USD 2.975 N/A (N/A)
NASDAQ Delayed 15 minutes
Oct 16 Close
1-Day High 52-Week High P/E 1-Day Volume Mkt Cap ($Mil)
N/A 0.000 N/A N/A 233.60
1-Day Low 52-Week Low Yield Avg. Volume  
N/A 0.000 0.0% 1,771,858  

Latest 10 SEC filings (by transaction date) for SRNE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 2/17 Oct 2/17 Followwill Dorman Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 18/17 Sep 15/17 Wu Yue Alexander Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Deming David H Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Janda Kim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Shah Jaisim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 15/17 Sep 15/17 Deming David H Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 15/17 Sep 15/17 Janda Kim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 15/17 Sep 15/17 Shah Jaisim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 15/17 Sep 15/17 Wu Yue Alexander Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 14/17 Ferrigno Dean Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 25,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Latest 10 SEC filings (by filing date) for SRNE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction # or value acquired or disposed of Price
Oct 2/17 Oct 2/17 Followwill Dorman Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 18/17 Sep 15/17 Wu Yue Alexander Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Deming David H Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Janda Kim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 15/17 Shah Jaisim Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sep 18/17 Sep 14/17 Ferrigno Dean Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 25,000  
Sep 15/17 Sep 14/17 Ji Henry Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 750,000  
Sep 15/17 Sep 14/17 Ng George K Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 150,000  
Sep 15/17 Sep 14/17 Zeldis Jerome B Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 150,000  
Sep 15/17 Sep 15/17 Deming David H Direct Ownership Stock Options A - Grant, award or other under Rule 16b-3(d) 35,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months. During our beta offer, get free access to company PDF reports.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. During our beta offer, get free access to company PDF reports.
Get holdings trends & enhanced insider charts in PDF now
Share an Idea with Easy Blurb
140

Twitter

Search (past week) for $SRNE

StockTwits